Icure Pharmaceutical Incorporation Market Cap ($54.96 Million)

$54.96 Million USD · ₩81.09 Billion KRW · Rank #21329

Market Cap & Net Worth: Icure Pharmaceutical Incorporation (175250)

Icure Pharmaceutical Incorporation market cap. Icure Pharmaceutical Incorporation (KQ:175250) has a market capitalization of $54.96 Million (₩81.09 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #21329 globally and #1258 in its home market, demonstrating a 0.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Icure Pharmaceutical Incorporation's stock price ₩2170.00 by its total outstanding shares 37369700 (37.37 Million). Also see Icure Pharmaceutical Incorporation operating cash flow efficiency for how efficiently the company converts equity into cash flow.

Icure Pharmaceutical Incorporation Market Cap History (2018–2025)

Icure Pharmaceutical Incorporation market cap history from 2018 to 2025. Data shows change from $249.84 Million to $54.96 Million (-25.91% CAGR). Check 175250 stock price and chart for real-time trading data and today's change.

Index Memberships

Icure Pharmaceutical Incorporation is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$203.83 Billion	0.03%	#578 of 1384
Kosdaq Composite Index KQ11	$203.83 Billion	0.03%	#578 of 1384

Weight: Icure Pharmaceutical Incorporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Icure Pharmaceutical Incorporation Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Icure Pharmaceutical Incorporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Icure Pharmaceutical Incorporation annual equity growth to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.00x

Icure Pharmaceutical Incorporation's market cap is 0.00 times its annual revenue

Industry average: 0.58x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.04x

Icure Pharmaceutical Incorporation's market cap is 0.04 times its annual earnings

Industry average: 13.51x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2018	$249.84 Million	$33.32 Billion	-$7.89 Billion	0.01x	N/A
2019	$273.28 Million	$60.92 Billion	-$8.75 Billion	0.00x	N/A
2020	$476.25 Million	$90.14 Billion	-$12.61 Billion	0.01x	N/A
2021	$330.20 Million	$64.28 Billion	-$38.17 Billion	0.01x	N/A
2022	$64.71 Million	$59.37 Billion	-$41.77 Billion	0.00x	N/A
2023	$52.93 Million	$56.81 Billion	-$31.42 Billion	0.00x	N/A
2024	$45.96 Million	$69.21 Billion	$1.05 Billion	0.00x	0.04x

Competitor Companies of 175250 by Market Capitalization

Companies near Icure Pharmaceutical Incorporation in the global market cap rankings as of November 4, 2026. Also see Icure Pharmaceutical Incorporation total assets for a full breakdown of the balance sheet.

Key companies related to Icure Pharmaceutical Incorporation by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#509	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#534	GALDERMA GROUP AG	NYSE:GALDY	$50.42 Billion	$45.90
#580	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$46.03 Billion	CN¥49.31
#618	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€18.50

Market Capitalization of Icure Pharmaceutical Incorporation (2018–2025)

Market capitalization of Icure Pharmaceutical Incorporation from 2018 to today. Between 2018 and today, Icure Pharmaceutical Incorporation's market cap moved from $249.84 Million to $ 54.96 Million, with a yearly change of -25.91%.

Year	Market Cap	Change (%)
2025	₩54.96 Million	+19.56%
2024	₩45.96 Million	-13.16%
2023	₩52.93 Million	-18.20%
2022	₩64.71 Million	-80.40%
2021	₩330.20 Million	-30.67%
2020	₩476.25 Million	+74.27%
2019	₩273.28 Million	+9.38%
2018	₩249.84 Million	--

End of Day Market Cap According to Different Sources

On Aug 4th, 2026 the market cap of Icure Pharmaceutical Incorporation was reported to be:

Source	Market Cap
Yahoo Finance	$54.96 Million USD
MoneyControl	$54.96 Million USD
MarketWatch	$54.96 Million USD
marketcap.company	$54.96 Million USD
Reuters	$54.96 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Icure Pharmaceutical Incorporation

KQ:175250 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$54.96 Million

₩81.09 Billion KRW

Market Cap Rank

#21329 Global

#1258 in Korea

Share Price

₩2170.00

Change (1 day)

+0.00%

52-Week Range

₩2170.00 - ₩2170.00

All Time High

₩23730.97